Both in Pharmaceuticals
Liquidia vs Ligand Pharmaceuticals
Over the past year LQDA returned +210.0% and LGND returned +79.3%; their daily moves had a correlation of 0.16.
LQDA +210.0% LGND +79.3%Growth of $1, one year, split-adjusted
| Metric | LQDA | LGND |
|---|---|---|
| Price | $70.69 | $310.36 |
| Market cap | $6.33B | $6.19B |
| Today | −4.05% | −1.19% |
| 1 month | +4.4% | +10.6% |
| 6 months | +100.9% | +61.1% |
| Year to date | +105.0% | +64.2% |
| 1 year | +224.3% | +82.9% |
| Revenue growth (YoY) | +1842.7% | +33.7% |
| Gross margin | 93.3% | 82.2% |
| Net margin | 43.5% | 76.2% |
| P/E (TTM) | 45.7× | 31.4× |
| Price / sales | 14.0× | 21.3× |
| Net cash | $108.1M | $244.1M |
| Dividend yield | — | — |
| Volatility (60d) | 61.2% | 28.5% |
| Short % of float | 18.7% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).